Tib neeg cov kua mis nyuj Oligosaccharides (HMOs, 2-tsom xam)

Tib neeg cov kua mis nyuj Oligosaccharides (HMOs, 2-tsom xam)
Paub meej:
Khoom npe: Tib neeg cov mis nyuj Odigosaccharides (HMOs, 2'-fucosyllactose)
  • 2 Cas. 41263-94-9
  • 1 Molecular Cov Qauv C18H32O15
  • 3Molecular hnyav 488.44
  • 6 Kev tshwm sim Tawm-dawb hmoov
  • 5 Chaw ntim khoom Khw ntawm -20℃~ 8℃hauv qhov chaw qhuav thiab txias
Xa kev nug
Ces
Hauj lwm lawm
Kev tsis

 

Daim ntawv thov

 

Txoj kev tshawb no pom tias HMOs hauv tib neeg cov kua mis yog suav ntawm tsib tus monomers: D-fluetyllucosamine (GLCNAC), L-FUCUCT (FUC) thiab sialic acid (somic acid (sialic acid Sa), no tsib cov monomers sib xyaw ua ke hauv cov sib txawv ua kom ntau txhiab HMOs hauv niam mis.

 

HMOs yog tus noj zaub mov thib peb rau hauv cov kua mis thiab ua ib qho kev loj hlob thib ob thiab kev loj hlob, thiab siab dua cov protein (txog 10g / l). Ntau tshaj 200 qhov sib txawv HMOs tau txheeb xyuas, thiab txhua HMO yuav muaj txoj haujlwm sib txawv. Cov ntsiab lus ntawm HMOs hauv colostrum tuaj yeem ncav cuag 20-25g / u, thiab theem ntawm cov kua mis ua kom tsawg dua li 10-15G

Lub tsev

 

product-368-263

HMOs tuaj yeem tiv thaiv cov kab mob streptococcal tuag, tshwj xeeb tshaj yog lacto-n-difucohose, uas txhawb nqa cov kab mob muaj txiaj ntsig zoo hauv plab thiab tiv thaiv tus mob GBS;

 

Lawv tuaj yeem ua haujlwm raws li anti-adhesion cov neeg sawv cev lossis receptor kom nres pathogens li cov kab mob thiab cov kab mob los ntawm cov piam thaj ntawm cov epithelial hlwb;

 

Lawv tuaj yeem ua haujlwm rau immunomodulators hloov tus tswv epithelial thiab tiv thaiv cov lus teb ntawm tes, uas muaj txiaj ntsig zoo rau kev noj qab haus huv;

 

Lawv tuaj yeem ua haujlwm li Prebiansics los hloov cov pleev pleev pob txha hnyuv puab.

 

Ntawm ntau tshaj 200 oligosaccharides hauv tib neeg cov kua mis, 2-fucosyllactose (2 '-fl) yog ntau tshaj nyob rau HMOs. Ci ntsa iab tsim 2'-fucosyllactose los ntawm microbial fermentation ntawm Transgenic E. coli hom. Raws li cov microbial tus kheej (lossis simulated) medicalynism, cov qauv siv hluav taws xob ib puag ncig ntawm cov txheej txheem hluav taws xob thiab cov tshuaj lom neeg (cov tshuaj lom neeg, enzyme catalysis, thiab lwm yam).

 

Xyoo 2015, 2 '-fl tau pom zoo los ntawm EU raws li cov khoom noj khoom haus tshiab khoom noj khoom haus cov khoom siv hluavtaws; Hauv Tebchaws Asmeskas, FDA tau pom zoo 2'-fl raws li gras cov khoom xyaw. Nws yog siv los ua cov khoom xyaw hauv thawj-theem mos liab (0-1 xyoo), thib ob-1 xyoos), cov mis mos-1, thiab cov ntawv noj mis mos tshwj xeeb.

 

Daim Ntawv Pov Thawj Zaub

 

product-1561-480

 

Cov duab nthuav tawm

 

product-1562-559

 

Tuam txhab tau

 

product-1561-649

 

Cim npe nrov: tib neeg cov mis nyuj oligosaccharides (HMOs, 2-tsom xam), Suav tib neeg cov mis O Oligosaccharides (HMOs, 2-nplooj ntawv) tuam ntxhab, cov chaw tsim khoom

Xa kev nug